Bühlmann, M

Bühlmann, M; Walrad, Pegine; Rico, E; Ivens, A; Capewell, P; Naguleswaran, Arunasalam; Roditi, Isabel; Matthews, K (2015). NMD3 regulates both mRNA and rRNA nuclear export in African trypanosomes via an XPOI-linked pathway. Nucleic acids research, 43(9), pp. 4491-4504. Oxford University Press 10.1093/nar/gkv330

Rochlitz, C; Ruhstaller, T; Lerch, S; Spirig, C; Huober, J; Suter, T; Bühlmann, M; Fehr, M; Schönenberger, A; von Moos, R; Winterhalder, R; Rauch, D; Müller, A; Mannhart-Harms, M; Herrmann, R; Cliffe, B; Mayer, M; Zaman, K; Swiss Group for Clinical Cancer Research, (SAKK) (2011). Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06). Annals of oncology, 22(1), pp. 80-5. Oxford: Oxford University Press 10.1093/annonc/mdq319

Zbinden, S; Bühlmann, M; Aebi, S; Suter, T (2010). Kardiovaskuläre Nebenwirkungen der modernen, medikamentösen Krebstherapie. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, pp. 143-147. Basel: EMH Editores Medicorum Helveticorum

Ernst, S; Bühlmann, M; Stucki, A; Bükki, J; Stanga, Z (2007). [What is your diagnosis? Neutropenic colitis (neutropenic typhlitis)]. Praxis - schweizerische Rundschau für Medizin, 96(4), pp. 99-100. Bern: Huber